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ARTICLE INFO
Dear Editor,
We greatly enjoyed reading the excellent review by Hol-
linger  and  colleagues  on  occult  hepatitis  B  infection  in 
chronic hemodialysis (HD) patients (1). As Hollinger et al. 
mentioned  in  their  review,  few  studies  have  shown  the 
prevalence of occult hepatitis B virus (HBV) infection in HD 
patients. Due to the parenteral transmission of HBV, HD pa-
tients are at high risk of acquiring this virus because they 
need  frequent  blood  transfusions  and  undergo  medical 
procedures that accompany bleeding (2). The prevalence of 
occult HBV infection in these patients is between 0 to 58% 
(3-5). The different frequencies of occult HBV infection in HD 
patients may be due to variation in the prevalence of HBV 
infection  among  countries,  sensitivity  of  molecular  tech-
niques, and the size and virological features of the study 
groups. In one study, we determined the rate of occult HBV 
infection in Iranian HD patients with isolated hepatitis B 
core antibody (anti-HBc) (6). Of 289 patients enrolled in this 
study, 18 subjects had isolated anti-HBc and HBV-DNA was de-
tected in 50% of patients who had isolated anti-HBc. Plasma 
HBV-DNA load was less than 50 IU/ml in each patient. Our in-
vestigation showed that occult HBV infection was common 
in HD patients with isolated anti-HBc regardless of age, sex, 
aminotransferases levels, or length of time on dialysis (6). 
Our data is in agreement with the results of hollinger et al. 
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